tiprankstipranks
Advertisement
Advertisement

JP:4506 Stock Latest News

Is DNPUF a Buy, Before Earnings?
Pre-EarningsIs DNPUF a Buy, Before Earnings?
4d ago
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
PremiumCompany Announcements
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
9d ago
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
PremiumCompany Announcements
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
9d ago
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
PremiumCompany Announcements
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
25d ago
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
PremiumCompany Announcements
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
1M ago
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
PremiumCompany AnnouncementsSumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
1M ago
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
Premium
Company Announcements
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
1M ago
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
Premium
Company Announcements
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
2M ago
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
PremiumCompany Announcements
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
3M ago
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
PremiumCompany Announcements
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
3M ago
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
PremiumCompany Announcements
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
3M ago
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
PremiumCompany Announcements
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
3M ago
Sumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review
PremiumCompany AnnouncementsSumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review
3M ago
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
Premium
Company Announcements
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
4M ago
Sumitomo Pharma Outlines Q3 FY2025 Results With Caution on Forward-Looking Data
Premium
Company Announcements
Sumitomo Pharma Outlines Q3 FY2025 Results With Caution on Forward-Looking Data
4M ago
Is DNPUF a Buy, Before Earnings?
PremiumPre-Earnings
Is DNPUF a Buy, Before Earnings?
4M ago
Sumitomo Pharma Reports Strong Half-Year Results and Raises Full-Year Forecasts
PremiumCompany Announcements
Sumitomo Pharma Reports Strong Half-Year Results and Raises Full-Year Forecasts
7M ago
Sumitomo Pharma Completes Strategic Sale in Asian Business Restructuring
PremiumCompany Announcements
Sumitomo Pharma Completes Strategic Sale in Asian Business Restructuring
7M ago
DNPUF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
DNPUF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe FlySumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
9M ago
Sumitomo Pharma Reports Significant Foreign Exchange Loss in Q1
Premium
Company Announcements
Sumitomo Pharma Reports Significant Foreign Exchange Loss in Q1
10M ago
Sumitomo Pharma Completes Asian Business Transfer to Marubeni
Premium
Company Announcements
Sumitomo Pharma Completes Asian Business Transfer to Marubeni
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >